Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

Álvaro Aparisi, Pablo Catalá, Ignacio J. Amat‐Santos, Marta Marcos-Mangas, Diego López‐Otero, Carlos Alberto Gurgel Veras, Javier López‐País, Gonzalo Cabezón Villalba, Carla Eugenia Cacho Antonio, Jordi Candela, Pablo Antúnez‐Muiños, José Francisco López Gil, Teba González Ferrero, Gino Rojas, Marta Pérez-Poza, Aitor Uribarri, Óscar Otero García, Pablo Elpidio García-Granja, Víctor Jiménez Ramos, Ana Revilla, Carlos Dueñas, Itzíar Gómez, José Ramón González‐Juanatey, J. Alberto San Román